Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Olek EA"'
Autor:
McCoach CE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Present Address: Genentech, Inc., South San Francisco, California. Electronic address: caroline.mccoach@ucsf.edu., Rolfo C; Greenebaum Comprehensive Cancer Center, Experimental Therapeutics Program, School of Medicine, University of Maryland, Baltimore, Maryland; Present Address: Center for Thoracic Oncology at Tisch Cancer Institute, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York., Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Lacouture M; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Besse B; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Zhu VW; Department of Medicine, Division of Hematology and Oncology, University of California Irvine, Orange, California., Tan DSW; National Cancer Centre Singapore, Duke-National University of Singapore Medical School, Singapore., Farajian S; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Potter LA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Present Address: Davis School of Medicine, University of California, Sacramento, Sacramento, California., Kherani JF; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Soldatenkova V; Eli Lilly and Company, Indianapolis, Indiana., Olek EA; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Muehlenbein CE; Eli Lilly and Company, Indianapolis, Indiana., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Jun; Vol. 17 (6), pp. 768-778. Date of Electronic Publication: 2022 Feb 17.
Autor:
Rosen EY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Johnson ML; Department of Medicine, Sarah Cannon Cancer Center, Nashville, Tennessee., Clifford SE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Somwar R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Kherani JF; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Son J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bertram AA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Davare MA; Oregon Health and Science University, Portland, Oregon., Gladstone E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Ivanova EV; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Henry DN; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Kelley EM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lin M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Milan MSD; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nair BC; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Olek EA; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Scanlon JE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Vojnic M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Ebata K; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Hechtman JF; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Taylor BS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rothenberg SM; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. drilona@mskcc.org.; Weill Cornell Medical College, New York, New York., Oxnard GR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jan 01; Vol. 27 (1), pp. 34-42. Date of Electronic Publication: 2020 Oct 20.
Autor:
Shen, Jiayi1 (AUTHOR) shenjiayi890813@163.com, Chen, Liping1 (AUTHOR), Song, Yulan1 (AUTHOR), Chen, Sheng2 (AUTHOR) chensheng0813@163.com, Guo, Wei1 (AUTHOR) guoweigw@126.com, Li, Yongdong1 (AUTHOR) ydli2011@163.com
Publikováno v:
AAPS Open. 6/17/2024, Vol. 10 Issue 1, p1-13. 13p.
Autor:
Lysyy T; Department of Surgery Yale University School of Medicine New Haven CT USA., Lalani AS; Puma Biotechnology, Inc. Los Angeles CA USA., Olek EA; Puma Biotechnology, Inc. Los Angeles CA USA., Diala I; Puma Biotechnology, Inc. Los Angeles CA USA., Geibel JP; Department of Surgery Yale University School of Medicine New Haven CT USA.; Department of Cellular and Molecular Physiology Yale University School of Medicine New Haven CT USA.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2019 Sep 13; Vol. 7 (5), pp. e00521. Date of Electronic Publication: 2019 Sep 13 (Print Publication: 2019).
Autor:
Haohai Huang1,2, Dan Liao3, Bin He4, Yejia Cui5, Rong Pu5 rongpuclinical@163.com, Guanghui Zhou6 zhouguanghui2072@163.com
Publikováno v:
Iranian Journal of Basic Medical Sciences. Aug2022, Vol. 25 Issue 8, p997-1001. 5p.
Publikováno v:
Frontiers of Medicine; Apr2023, Vol. 17 Issue 2, p207-219, 13p
Autor:
Eun Jung Lee1, Ran Song1, Ji-Na Park1, Yeon-Ah Lee1, Jun Seong Son2, Seung-Jae Hong1, Hyung-In Yang1, Sang-Hoon Lee1 boltaguni@yahoo.co.kr
Publikováno v:
International Journal of Rheumatic Diseases. Aug2010, Vol. 13 Issue 3, pe16-e19. 4p. 6 Black and White Photographs.
Autor:
Uçan, Eyüp Sabri, Sevinç, Can, Kurtar, Nazan, Hayretdağ, Ahu Yalabık, Osma, Emine, Şimşek, İlyak, Kargı, Aydanur
Publikováno v:
Turkish Thoracic Journal / Turk Toraks Dergisi; Apr2001, Vol. 2 Issue 1, p44-49, 6p
Progressing from general scientific principles and concepts to in-depth topical discussions of current research and treatment methods, this comprehensive reference defines the cellular and molecular mechanisms contributing to inflammatory lung injury
